Pages that link to "Q36942524"
Jump to navigation
Jump to search
The following pages link to Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant (Q36942524):
Displaying 26 items.
- Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant (Q33884322) (← links)
- Anti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model (Q33958630) (← links)
- Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinoma (Q34075588) (← links)
- Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis (Q34079161) (← links)
- Survivin is a novel target of CD44-promoted breast tumor invasion (Q35168013) (← links)
- Differential effect of phosphorylation-defective survivin on radiation response in estrogen receptor-positive and -negative breast cancer (Q35170677) (← links)
- Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A. (Q35488154) (← links)
- Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73 (Q36343925) (← links)
- Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model (Q36905311) (← links)
- Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma (Q37238522) (← links)
- Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant (Q37593002) (← links)
- Survivin-T34A: molecular mechanism and therapeutic potential. (Q37834973) (← links)
- Nanotechnology based platforms for survivin targeted drug discovery (Q38040859) (← links)
- A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. (Q38744748) (← links)
- Plasmid-encoding vasostatin inhibited the growth and metastasis of human hepatocellular carcinoma cells (Q38977768) (← links)
- Tithonia diversifolia and its main active component tagitinin C induce survivin inhibition and G2/M arrest in human malignant glioblastoma cells (Q39632401) (← links)
- Inhibition of human lung adenocarcinoma growth using survivint34a by low-dose systematic administration (Q39670640) (← links)
- Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo (Q39703963) (← links)
- Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model (Q39723159) (← links)
- Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer (Q39729927) (← links)
- Antitumor effect of mSurvivinThr34→Ala in murine colon carcinoma when administered intravenously (Q43233318) (← links)
- Targeting PRPK Function Blocks Colon Cancer Metastasis. (Q52684446) (← links)
- Novel CD44-downstream signaling pathways mediating breast tumor invasion (Q59137664) (← links)
- In vivo antitumor activity of liposome‑plasmid DNA encoding mutant survivin‑T34A in cervical cancer (Q88690509) (← links)
- The Ectopic Expression of SurvivinT34A and FilC Can Enhance the Oncolytic Effects of Vaccinia Virus in Murine Gastric Cancer (Q89883757) (← links)
- Inhibition of tumor growth and angiogenesis by 2-(4-aminophenyl) benzothiazole in orthotopicglioma C6 rat model (Q90039740) (← links)